Prevention of venous thromboembolism

Chest. 2001 Jan;119(1 Suppl):132S-175S. doi: 10.1378/chest.119.1_suppl.132s.

Authors

W H Geerts¹, J A Heit, G P Clagett, G F Pineo, C W Colwell, F A Anderson Jr, H B Wheeler

Affiliation

¹ Thromboembolism Program, Sunnybrook & Women's College Health Sciences Centre, Toronto, ON, Canada.

PMID: 11157647
DOI: 10.1378/chest.119.1_suppl.132s

No abstract available

Publication types

Research Support, Non-U.S. Gov't
Review

MeSH terms

Burns / complications
Critical Care
Fibrinolytic Agents / therapeutic use*
Heparin / therapeutic use
Heparin, Low-Molecular-Weight / therapeutic use
Humans
Myocardial Infarction / drug therapy
Neoplasms / complications
Postoperative Complications / drug therapy
Postoperative Complications / prevention & control
Pulmonary Embolism / prevention & control*
Risk Assessment
Spinal Cord Injuries / complications
Stroke / drug therapy
Venous Thrombosis / epidemiology
Venous Thrombosis / prevention & control*
Wounds and Injuries / complications

Substances

Fibrinolytic Agents
Heparin, Low-Molecular-Weight
Heparin